SEC Form 4/A · accession 0001019687-16-004875
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Yuichi Iwaki
Officer — President and CEO · Director
Period of report
Jan 7, 2016
Accepted (ET)
Jan 19, 2016 · 6:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.09 | Jan 7, 2016 | A | 250,000 | A | Jan 7, 2016 | Jan 6, 2025 | Common Stock | 250,000 | 250,000 | D |
| Employee Stock Option (Right to Buy)F2,F3 | $3.91 | Jan 7, 2016 | A | 120,000 | A | — | Jan 6, 2026 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F1On January 7, 2015, the reporting person was granted an option to purchase 250,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2015. The Performance criteria have been met, resulting in full vesting of the option.
- F2This report is being amended to correct the exercise price of the option based on the closing price of the common stock on the grant date as reported by NASDAQ.
- F3The option vests over a period of 3 years in equal monthly installments from the 01-07-2016 date of grant.